Form D · Biotechnology

PROTEA BIOSCIENCES INC

Morgantown, WV · CIK 0001194490

Offering snapshot reported May 5, 2011 · SEC filing

Reported sold
$1.05M
Offering amount: $5M
Investors reported
8
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Apr 28, 2011
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 5, 2011Initial$1,050,000No comparison8SEC filing
Jan 14, 2011Amendment$7,490,000$7,310,000vs Aug 12, 200984SEC filing
Aug 12, 2009Initial$180,000No comparison3SEC filing
Jul 15, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Jan 29, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Aug 24, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Jun 4, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Jun 4, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Jun 4, 2007PaperNot reportedNo comparisonNot reportedSEC filing
May 22, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-159321

Source: Form D, filed May 5, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Steve Antoline Director
Jesse Ayers Executive
Thomas Clark Director
Daniel Flynn Director
Leonard P. Harris Director
Stanley M. Hostler Director, Executive
Roderick Jackson Director
Harris Leo Director
Milan Puskar Director
Ed Roberson Director
Scott Segal Director
Stephen Turner Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
955 Hartman Run Road Suite 210
Morgantown, WV, 26507